Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2004

View Archived Issues

Therapeutic benefits of recombinant PSA vaccines in advanced prostate cancer

Pulmicort HFA-MDI completes phase III

CDC recommends resumption of third Prevnar dose

Positive data, revised phase III plans for naveglitazar

BresaGen completes U.S. merger with Cythera

Positive phase II results for Allox

Abbott plans Xinlay NDA filing later this year

New phase II trial for M-40403

Enrollment begins in phase II Xcytrin study for metastatic renal cell carcinoma

Second subgroup in Sinovac SARS vaccine phase I trials receives inoculations

MS-325 in new post-NDA program

Phase IIb study evaluates Reverset in HIV patients failing therapy

Tacrolimus results presented at pediatric dermatology congress

Novel insulin-like growth factor-I receptor kinase inhibitors against tumor growth

Zafirlukast induces symptomatic response in women with recurrent VVC

Clinical evidence for the efficacy of pregabalin in painful diabetic neuropathy

Salbutamol reported to improve muscle strength in children with congenital myopathies

Benzoxazinone derivatives for the treatment of CNS and other disorders

Selective angiotensin AT2 receptor agonists described by Vicore Pharma

Nonsteroidal modulators of farnesoid X receptors described in patent literature

Takeda patent claims compounds that inhibit somatostatin receptor binding

Inhibitors of receptor tyrosine kinases claimed by Array BioPharma

CRF1 receptor antagonists for anxiety, affective disorders, etc.

Good safety and acceptability profile found with Carraguard in HIV-positive patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...